AVID Medical Urgent Recall: Angiographic Syringes in Convenience Kits
Summary
FDA CDRH issued an Early Alert notifying the public that AVID Medical initiated an urgent medical device recall for convenience kits containing angiographic syringes affected by Medline's Namic RA Syringes recall. The recall involves 11 tray configurations with specific model numbers and UDI-DIs. Affected customers must identify, quarantine, and add warning labels to affected kits, with direction to remove and destroy Namic RA Syringes due to risk of serious injury or death.
What changed
AVID Medical issued an urgent recall notification for convenience kits containing angiographic syringes affected by Medline's Namic Angiographic Control Syringes recall. The syringe rotating adaptor on affected devices may pose serious safety risks. Affected products span 11 tray configurations including CARDIAC CATH PACK, SAMMC ANGIOGRAPHY, HEART CATH, VA DETROIT CATH LAB PACK, CATH LAB, CARDIAC CATH TRAY, PERC TRAY, and NEURO IR PERIPHERAL kits.
Healthcare providers and facilities with affected kits on hand must immediately segregate and quarantine products, apply warning labels, and remove/destroy Namic RA Syringes. If use is unavoidable to prevent patient harm, extreme caution including manual stabilization of syringe-to-manifold connections and 100% continuous monitoring during procedures is required. Distributors who resold or transferred affected products must notify customers of this recall.
What to do next
- Identify and quarantine all affected convenience kits containing Namic RA syringes
- Apply warning labels to affected kits using AVID's labeling template
- Remove and destroy all Namic RA Syringes from affected kits
Penalties
Risk of serious injury or death if affected syringes are used without proper precautions
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CDRH is issuing this Early Alert **to notify the public of a potentially high-risk device issue.* The FDA will keep the public informed and update this web page as significant new information becomes available.*
Affected Product
The FDA is aware that AVID Medical has issued an Urgent Medical Device Recall Notification to affected customers recommending certain angiographic syringes included in convenience kits be removed from where they are used or sold. Affected devices:
| Description (Tray Name) | Model/Item Number | UDI-DI |
|---|---|---|
| CARDIAC CATH PACK | EAMC1000-05 | 10809160377314 |
| SAMMC ANGIOGRAPHY | SAMM066-15 | 10809160388495 |
| HEART CATH, SELF REGIONAL | SELF131-05 | 10809160408650 |
| VA DETROIT CATH LAB PACK | VMCD029 | 10809160388969 |
| CATH LAB | SACL75AM | 20809160481377 |
| CARDIAC CATH TRAY SHANDS JAX | SHND401-04 | 10809160395615 |
| CARDIAC CATH PACK | WAFB208-02 | 10809160424759 |
| PERC TRAY | SLPC34-01 | 10809160511213 |
| CARDIAC CATH PACK SAN23CARDQ | DRCC36 | 10809160469088 |
| NEURO IR PERIPHERAL (PS 64405) | UINR44-01 | 20809160454439 |
| CATH LAB | SACL75-01 | 20809160481377 |
What to Do
Identify kits with affected syringes. Apply over-labels to all affected kits on hand stating that the affected syringes must be removed and discarded from further use.
On March 13, AVID Medical sent all affected customers a letter recommending the following actions:
- Identify, segregate, and quarantine all affected product.
- Add warning labels to all affected kits stating that the affected syringes must be removed and discarded from further use.
- Use the labeling template provided by AVID to print labels. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling.
- If you are a distributor or have resold or transferred this product, notify them of this recall communication.
- Per Medline, due to the risk of serious injury or death, customers are directed to remove and destroy all Namic RA Syringes. If use is unavoidable because failure to proceed would result in patient harm, the Namic RA syringe must be used with extreme caution and vigilance, including manual stabilization of syringe-to-manifold connections and continuous, 100% monitoring during setup and throughout the entire procedure.
- All usage guidelines and the Instructions for Use are provided in Medline’s recall letter. Strict adherence to all usage guidelines and the Instructions for Use are required. Check this web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.
Reason for Alert
AVID Medical initiated an urgent Medical Device Recall notification for convenience kits that contain syringes affected by Medline’s Namic Angiographic Control Syringes with Rotating Adaptor (“Namic RA Syringes”) recall.
Medline Industries stated that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. If unwinding occurs, there is potential for biohazard exposure, blood loss, and infection. Loose connections or disconnections may introduce air into the line, which could result in air embolism. These conditions may lead to serious injury or death. All units have the potential to exhibit this failure mode.
As of March 13, Medline Industries has reported four serious injuries and no deaths associated with this issue.
Device Use
Convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components that are intended to be used during various surgical procedures.
Contact Information
Customers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact AVID Medical at complaints@owens-minor.com.
Additional FDA Resources
- Angiographic Syringe Recall: Medline Industries Removes Namic Angiographic Rotating Adaptor Control Syringes [04/09/2026]
- FDA Enforcement Report for Medline Namic RA Syringes Recall
- CDRH Medical Device Recall Database for Medline Namic RA Syringes Recall
Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.
- How do I recognize a UDI on a label?
- AccessGUDID database - Identify Your Medical Device
- Benefits of a UDI System
How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
- ## Content current as of:
04/10/2026
-
Related changes
Get daily alerts for FDA Medical Device Recalls
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Medical Device Recalls publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.